Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal – sources

It’s possible because they have different expectations of profitability than multinationals so they can be happy with lower margins,” said Franck Le Deu, Hong Kong-based senior partner at consultancy McKinsey. “One complication of being in diabetes …
( read original story …)